Aug 2026
KRASG12V Degraders Provide a Potential Therapeutic Opportunity in Lung Adenocarcinoma.
PERTACs that degrade the KRAS oncoprotein are a promising modality for the treatment of lung adenocarcinomas, and resistance to PROTACs may differ from conventional KRAS inhibitors, suggesting potential strategies for overcoming such resistance.
S. Garcia Borrego, S. Misale
· Cancer Research · 0 citations